Literature DB >> 4050348

Carcinomatous meningeosis as exclusive metastasizing pattern in a malignant thymoma.

R Kleinert, G F Walter, G Kleinert.   

Abstract

In a 57-year-old male patient meningitic symptoms occurred. CSF cytology exhibited carcinoma cells, thus establishing the diagnosis of carcinomatous meningeosis. The primary site of the tumor or metastases were not detected intra vitam. The autopsy revealed a malignant thymoma with an exclusive metastatic participation of the leptomeninges except for some few regional lymph nodes. Cerebral metastases of malignant thymoma is an extremely rare condition.

Entities:  

Mesh:

Year:  1985        PMID: 4050348     DOI: 10.1007/BF00687821

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  3 in total

1.  Thymomas: clinicopathologic features, therapy, and prognosis.

Authors:  M A Batata; N Martini; A G Huvos; R I Aguilar; E J Beattie
Journal:  Cancer       Date:  1974-08       Impact factor: 6.860

2.  Thymoma. A clinicopathologic study of 54 cases.

Authors:  G F Gray; W T Gutowski
Journal:  Am J Surg Pathol       Date:  1979-06       Impact factor: 6.394

3.  Cerebral metastasis from a malignant thymoma.

Authors:  J MacDonald; J C Parker; S Brown; L K Page; D E Wolfe
Journal:  Surg Neurol       Date:  1978-01
  3 in total
  3 in total

Review 1.  Cerebral involvement of metastatic thymic carcinoma.

Authors:  Doo-Sik Kong; Jung-Il Lee; Do Hyun Nam; Keunchil Park; Yeon-Lim Suh
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

Review 2.  Thymic carcinoma. Report of five cases and review of the literature.

Authors:  C A Hartmann; C Roth; C Minck; G Niedobitek
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

3.  Thymic carcinoma with brain metastasis mimicking meningioma.

Authors:  Jung Yong Ahn; Nam Keun Kim; Doyeun Oh; Hui Jung Ahn
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.